Literature DB >> 9619037

[Decreasing sarcoplasmic reticular calcium gives rise to myocardial protection--the effect of thapsigargin for myocardial protection under conditions of normothermia].

Y Kumada1, F Yamamoto, H Yamamoto, T Ishikawa, K Kagisaki, H Hirose.   

Abstract

Deceasing sarcoplasmic reticular (SR) calcium may contribute to the myocardiac protection against ischemia and reperfusion-induced injury. Therefore, using the isolated working rat heart model, we investigated the effect of Thapsigargin (TH)-induced SR calcium diminution on the myocardial protection when added either before onset of ischemia or at time of reperfusion under conditions of normothermic ischemia. Hearts (n = 6/group) from male Wistar rats were aerobically (37 degrees C) perfused (20 min) with bicarbonate buffer. In the experimental protocol A, this was followed by a 3 min infusion of St. Thomas' Hospital cardioplegic solution No. 2 (STS) containing various concentrations of TH. Hearts were then subjected to 34 min of normothermic (37 degrees C) global ischemia and 35 min of reperfusion (15 min Langendorff, 20 min working). Reperfusion cardiac functions at 20 min of working perfusion was measured and compared with the preischemia values. STS added to 0.1 and 0.25 mumol/L TH improved recovery of aortic flow after 20 min reperfusion from 47 +/- 3% in the TH free controls to 62 +/- 3, 63 +/- 2% (n = 6) (p < 0.05). There was no difference in creatine kinase (CK) leakage during Langendorff reperfusion between the TH treated groups and the control group. In the experimental protocol B, 3 min of cardioplegia without TH and 34 min of ischemia (37 degrees C) were followed by a 10 min Langendorff reperfusion with various concentrations of TH, then 10 min Langendroff reperfusion for washing out, and 20 min working reperfusion. When TH was added to reperfusate the recovery of aortic flow did not change, 0.5 mumol/L TH group had the detelious effect. Thus, TH, when added to the cardioplegia, enhanced myocardial protection. We conclude that lessened uptake of Ca2+ into sarcoplasmic reticulum by inhibitors of the Ca(2+)-ATPase pump can decrease ischemia and reperfusion-induced injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619037     DOI: 10.1007/bf03217757

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  22 in total

1.  Reversibility of the effects of normothermic global ischemia on the ryanodine-sensitive and ryanodine-insensitive calcium uptake of cardiac sarcoplasmic reticulum.

Authors:  M D Davis; W Lebolt; J J Feher
Journal:  Circ Res       Date:  1992-01       Impact factor: 17.367

2.  2,5-Di(tert-butyl)-1,4-benzohydroquinone--a novel inhibitor of liver microsomal Ca2+ sequestration.

Authors:  G A Moore; D J McConkey; G E Kass; P J O'Brien; S Orrenius
Journal:  FEBS Lett       Date:  1987-11-30       Impact factor: 4.124

3.  Effect of pressure development on oxygen consumption by isolated rat heart.

Authors:  J R Neely; H Liebermeister; E J Battersby; H E Morgan
Journal:  Am J Physiol       Date:  1967-04

4.  Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase.

Authors:  O Thastrup; P J Cullen; B K Drøbak; M R Hanley; A P Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

5.  Calcium efflux across the plasma membrane of rat parotid acinar cells is unaffected by receptor activation or by the microsomal calcium ATPase inhibitor, thapsigargin.

Authors:  H Takemura; O Thastrup; J W Putney
Journal:  Cell Calcium       Date:  1990-01       Impact factor: 6.817

6.  Accumulation of unesterified arachidonic acid in ischemic canine myocardium. Relationship to a phosphatidylcholine deacylation-reacylation cycle and the depletion of membrane phospholipids.

Authors:  K R Chien; A Han; A Sen; L M Buja; J T Willerson
Journal:  Circ Res       Date:  1984-03       Impact factor: 17.367

7.  Cardioplegia and slow calcium-channel blockers. Studies with verapamil.

Authors:  F Yamamoto; A S Manning; M V Braimbridge; D J Hearse
Journal:  J Thorac Cardiovasc Surg       Date:  1983-08       Impact factor: 5.209

8.  Prostacyclin biosynthesis and phospholipase activity in hypoxic rat myocardium.

Authors:  H Kawaguchi; H Yasuda
Journal:  Circ Res       Date:  1988-06       Impact factor: 17.367

9.  Inhibition of sarcoplasmic reticulum Ca(2+)-ATPase by 2,5-di(tert-butyl)-1,4-benzohydroquinone.

Authors:  H Nakamura; Y Nakasaki; N Matsuda; M Shigekawa
Journal:  J Biochem       Date:  1992-12       Impact factor: 3.387

10.  Cytoskeletal damage during myocardial ischemia: changes in vinculin immunofluorescence staining during total in vitro ischemia in canine heart.

Authors:  C Steenbergen; M L Hill; R B Jennings
Journal:  Circ Res       Date:  1987-04       Impact factor: 17.367

View more
  3 in total

1.  Novel role of HAX-1 in ischemic injury protection involvement of heat shock protein 90.

Authors:  Chi Keung Lam; Wen Zhao; Wenfeng Cai; Elizabeth Vafiadaki; Stela M Florea; Xiaoping Ren; Yong Liu; Nathan Robbins; Zhiguo Zhang; Xiaoyang Zhou; Min Jiang; Jack Rubinstein; W Keith Jones; Evangelia G Kranias
Journal:  Circ Res       Date:  2012-09-14       Impact factor: 17.367

2.  CaMKII-dependent phosphorylation of cardiac ryanodine receptors regulates cell death in cardiac ischemia/reperfusion injury.

Authors:  Mariano N Di Carlo; Matilde Said; Haiyun Ling; Carlos A Valverde; Verónica C De Giusti; Leandro Sommese; Julieta Palomeque; Ernesto A Aiello; Darlene G Skapura; Gustavo Rinaldi; Jonathan L Respress; Joan Heller Brown; Xander H T Wehrens; Margarita A Salas; Alicia Mattiazzi
Journal:  J Mol Cell Cardiol       Date:  2014-06-17       Impact factor: 5.000

3.  Endoplasmic Reticulum Stress/Ca2+-Calmodulin-Dependent Protein Kinase/Signal Transducer and Activator of Transcription 3 Pathway Plays a Role in the Regulation of Cellular Zinc Deficiency in Myocardial Ischemia/Reperfusion Injury.

Authors:  Huanhuan Zhao; Dan Liu; Qiumei Yan; Xiyun Bian; Jing Yu; Jingjing Wang; Xinxin Cheng; Zhelong Xu
Journal:  Front Physiol       Date:  2022-01-05       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.